查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1363093

制酸剂市场规模、份额和趋势分析报告：按类型、最终用途、地区、细分趋势，2023-2030

Antacids Market Size, Share & Trends Analysis Report By Type (Tablet, Liquid), By End-use (Retail Pharmacy, Hospital Pharmacy), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10个工作天内

价格

制酸剂市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球制酸剂市场规模预计将达到87.9亿美元，预测期内年复合成长率为3.7%。

偶尔胃灼热的自我治疗趋势是推动市场的主要因素之一。

老年人口的增加预计将对整个制酸剂市场产生积极影响。根据联合国经济和社会事务部（DESA）的数据，2017年全球老年人口（60岁以上）约为9.62亿。预计这一数字在拉丁美洲增长最快，其中 60 岁及以上人口数量增长了 71%，其次是亚洲（66%）、非洲（64%）、北美（41%）和欧洲（23%）。

经营制酸剂市场的主要企业正在专注于产品改进以满足患者需求，例如改变咀嚼片、粉末和果冻等剂型。此外，这些参与者也参与联盟和收购，以扩大其在市场上的影响力。例如，2017年，辉瑞与Astra Zeneca签署策略协议，以7.5亿印度卢比收购在印度的制酸剂品牌之一Neksium，加强产品系列。

制酸剂很容易在商店购买，为整体市场销售提供了成长机会。主要参与企业包括葛兰素史克、Astra Zeneca、辉瑞、太阳製药工业公司、雷迪博士实验室、拜耳和工业。

制酸剂市场报告亮点

  • 到 2022 年，锭剂将推动制酸剂市场，因为与其他剂型相比，其功效更高。液体製剂偏好好，深受儿童和老年人的喜爱，因此预计会快速成长。
  • 零售药局因其可近性和可用性而成为领先的配销通路。由于医药 3.0 的普及和消费者意识的提高，线上药局预计将成为成长最快的领域。
  • 由于葛兰素史克、辉瑞和雅培等主要参与者的存在，预计亚太地区将成为预测期内成长最快的地区。
  • 由于各种胃肠道疾病的盛行率不断增加，2022年北美占据了最大的市场占有率。

目录

第1章调查方法和范围

第2章执行摘要

第3章市场变数、趋势、范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 普及和成长前景图
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 制酸剂市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章市场：类型估计和趋势分析

  • 制酸剂市场：要点
  • 制酸剂市场：2022 年和 2030 年趋势和市场占有率分析
  • 锭剂
  • 液体
  • 其他的

第5章市场：最终用途估计与趋势分析

  • 制酸剂市场：要点
  • 制酸剂市场：2022 年和 2030 年趋势和市场占有率分析
  • 医院药房
  • 零售药房
  • 网路药房

第6章市场：区域估计与趋势分析

  • 区域展望
  • 按地区分類的制酸剂市场：要点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第7章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • GlaxoSmithKline plc.
    • Bayer AG
    • Pfizer, Inc.
    • Boehringer Ingelheim International GmbH
    • Dr. Reddy's Laboratories Ltd.
    • Reckitt Benckiser Group plc.
    • Sanofi
    • Sun Pharmaceuticals Ltd.
    • Takeda Pharmaceutical Company Limited
    • Procter & Gamble
Product Code: GVR-2-68038-693-6

Antacids Market Growth & Trends:

The global antacids market size is expected to reach USD 8.79 billion by 2030, registering a CAGR of 3.7% during the forecast period, according to a new report by Grand View Research, Inc. The trend of self-medication for occasional heartburn is one of the major factors driving the market.

Growing geriatric population is expected to positively impact the overall market for antacid. According to the United Nations Department of Economic And Social Affairs (DESA), the global elderly population (60 years and above), was around 962 million in 2017. This number is expected to grow at the fastest rate in Latin America with 71% increase in population aged 60 and over, followed by Asia with 66%, Africa with 64%, North America with 41%, and Europe with 23%.

Key players operating in antacid market focus on product enhancement to cater to patient requirements, such as changing the dosage form into chewable tablets, powder, and jelly. Also, these players are involved in collaborations and acquisitions to expand their market presence. For instance, in 2017, Pfizer, Inc. entered into a strategic agreement with AstraZeneca to acquire one of the antacid brands, Neksium for a value of INR 75 crores in India to boost its product portfolio.

The easy availability of antacids over-the-counter offer growth opportunities for the sales of overall market. Some of the key players areGlaxoSmithKline plc; AstraZeneca; Pfizer, Inc.; Sun Pharmaceuticals Industries Ltd.; Dr. Reddy's Laboratories Ltd.; Bayer AG; Takeda Pharmaceutical Company Limited.

Antacids Market Report Highlights:

  • In 2022, tablet segment led the antacid market due to high efficacy compared to other dosage forms. Liquid is anticipated to be the fastest growing segment due to its palatable taste and preferred choice for children and elderly population
  • Retail pharmacy led the distribution channel segment due its accessibility and availability. Online pharmacy is anticipated to be the fastest growing segment due to growing adoption of Pharma 3.0 and consumer awareness
  • Asia Pacific is estimated to be the fastest growing region over the forecast period due to presence of key players such as GlaxoSmithKline plc; Pfizer Inc.; and Abbott among others
  • North America held the largest market share in 2022 owing to increasing prevalence of different digestive disorders

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. End-use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. End-use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Antacids Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Antacids Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Antacids Market: Type Estimates & Trend Analysis

  • 4.1. Antacids Market: Key Takeaways
  • 4.2. Antacids Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Tablet
    • 4.3.1. Tablet market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Liquid
    • 4.4.1. Liquid market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Others
    • 4.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Antacids Market: End-use Estimates & Trend Analysis

  • 5.1. Antacids Market: Key Takeaways
  • 5.2. Antacids Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Hospital Pharmacy
    • 5.3.1. Hospital pharmacy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Retail Pharmacy
    • 5.4.1. Retail pharmacy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Online Pharmacy
    • 5.5.1. Online Pharmacy market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Antacids Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Antacids Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. f
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Denmark
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. GlaxoSmithKline plc.
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Bayer AG
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Pfizer, Inc.
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Boehringer Ingelheim International GmbH
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Dr. Reddy's Laboratories Ltd.
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Reckitt Benckiser Group plc.
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Sanofi
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Sun Pharmaceuticals Ltd.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Takeda Pharmaceutical Company Limited
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Procter & Gamble
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 3 North America antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 4 North America antacids market, by region, 2018 - 2030 (USD Billion)
  • Table 5 U.S. antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 6 U.S. antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 7 Canada antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 8 Canada antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 9 Europe antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 10 Europe antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 11 Europe antacids market, by region, 2018 - 2030 (USD Billion)
  • Table 12 Germany antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 13 Germany antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 14 UK antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 15 UK antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 16 France antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 17 France antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 18 Italy antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 19 Italy antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 20 Spain antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 21 Spain antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 22 Sweden antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 23 Sweden antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 24 Norway antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 25 Norway antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 26 Denmark antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 27 Denmark antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 28 Asia Pacific antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 29 Asia Pacific antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 30 Asia Pacific antacids market, by region, 2018 - 2030 (USD Billion)
  • Table 31 China antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 32 China antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 33 Japan antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 34 Japan antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 35 India antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 36 India antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 37 Australia antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 38 Australia antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 39 Thailand antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 40 Thailand antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 41 South Korea antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 42 South Korea antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 43 Latin America antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 44 Latin America antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 45 Latin America antacids market, by region, 2018 - 2030 (USD Billion)
  • Table 46 Brazil antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 47 Brazil antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 48 Mexico antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 49 Mexico antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 50 Mexico antacids market, by application, 2018 - 2030 (USD Billion)
  • Table 51 Argentina antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 52 Argentina antacids market, by application, 2018 - 2030 (USD Billion)
  • Table 53 Middle East and Africa antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 54 Middle East and Africa antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 55 Middle East and Africa antacids market, by region, 2018 - 2030 (USD Billion)
  • Table 56 South Africa antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 57 South Africa antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 58 Saudi Arabia antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 59 Saudi Arabia antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 60 Saudi Arabia antacids market, by application, 2018 - 2030 (USD Billion)
  • Table 61 UAE antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 62 UAE antacids market, by end-use, 2018 - 2030 (USD Billion)
  • Table 63 Kuwait antacids market, by type, 2018 - 2030 (USD Billion)
  • Table 64 Kuwait antacids market, by end-use, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approach
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Antacids: Market outlook
  • Fig. 9 Antacids: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Antacids market driver impact
  • Fig. 15 Antacids market restraint impact
  • Fig. 16 Antacids market strategic initiatives analysis
  • Fig. 17 Antacids market: Type movement analysis
  • Fig. 18 Antacids market: Type outlook and key takeaways
  • Fig. 19 Tablet market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Liquid market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Antacids market: End-use class movement analysis
  • Fig. 23 Antacids market: End-use outlook and key takeaways
  • Fig. 24 Hospital pharmacy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Retail pharmacy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Online pharmacy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Global antacids market: Regional movement analysis
  • Fig. 29 Global antacids market: Regional outlook and key takeaways
  • Fig. 30 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Europe. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)